Utility of cystatin C to monitor renal function in duchenne muscular dystrophy

Muscle and Nerve

Volumn 40, Issue 3, 2009, Pages 438-442

  Viollet, Laurence ^a   Gailey, Susan ^a   Thornton, David J ^a   Friedman, Neil R ^b   Flanigan, Kevin M ^c   Mahan, John D ^a   Mendell, Jerry R ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b LERNER RESEARCH INSTITUTE   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

Biomarker; Cystatin C; Duchenne muscular dystrophy; Renal function; Serum creatinine

Indexed keywords

BIOLOGICAL MARKER; CORTICOSTEROID; CREATININE; CYSTATIN C; DEFLAZACORT; PREDNISONE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ARTICLE; CHILD; CONTROLLED STUDY; CORTICOSTEROID THERAPY; CREATININE BLOOD LEVEL; DUCHENNE MUSCULAR DYSTROPHY; FEMALE; HUMAN; KIDNEY DISEASE; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MOBILIZATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADOLESCENT; ADRENAL CORTEX HORMONES; CHILD; CREATININE; CYSTATIN C; DEPENDENT AMBULATION; FEMALE; HUMANS; KIDNEY DISEASES, CYSTIC; MALE; MONITORING, PHYSIOLOGIC; MUSCULAR DYSTROPHY, DUCHENNE;

EID: 69749106139     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.21420     Document Type: Article

References (35)

1. Mathew TH, Johnson DW, Jones GR. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate: revised recommendations. Med J Aust 2007;187:459-463.
2. Davey RX. Chronic kidney disease and automatic reporting of estimated glomerular filtration rate. Med J Aust 2006;184:42-43; author reply 43.
3. Twomey PJ, Reynolds TM. The MDRD formula and validation. Q J Med 2006;99:804-805.
4. Rule AD, Larson TS, Bergstralh EJ, Slezak JM, Jacobsen SJ, Cosio FG. Using serum creatinine to estimate glomerular filtration rate: accuracy in good health and in chronic kidney disease. Ann Intern Med 2004;141:929-937.
5. Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med 2006;145:247-254. (Pubitemid 46768608)
6. Franciotta D, Zanardi MC, Albertotti L, Orcesi S, Berardinelli A, Pichiecchio A, et al. Measurement of skeletal muscle mass in Duchenne muscular dystrophy: use of 24-h creatinine excretion. Acta Diabetol 2003;40Suppl 1:S290-292. (Pubitemid 37322778)
7. Griggs RC, Forbes G, Moxley RT, Herr BE. The assessment of muscle mass in progressive neuromuscular disease. Neurology 1983;33:158-165. (Pubitemid 13137356)
8. Horio M, Imai E, Yasuda Y, Hishida A, Matsuo S. Simple sampling strategy for measuring inulin renal clearance. Clin Exp Nephrol 2009;13:50-54.
9. Piepsz A, Tondeur M, Ham H. Escaping the correction for body surface area when calculating glomerular filtration rate in children. Eur J Nucl Med Mol Imaging 2008;35:1669-1672.
10. Barton-Davis ER, Cordier L, Shoturma DI, Leland SE, Sweeney HL. Aminoglycoside antibiotics restore dystrophin function to skeletal muscles of mdx mice. J Clin Invest 1999;104:375-381. (Pubitemid 29534321)
11. Abrahamson M, Olafsson I, Palsdottir A, Ulvsback M, Lundwall A, Jensson O, et al. Structure and expression of the human cystatin C gene. Biochem J 1990;268:287-294. (Pubitemid 20193964)
12. Filler G, Bokenkamp A, Hofmann W, Le Bricon T, Martinez-Bru C, Grubb A. Cystatin C as a marker of GFR-history, indications, and future research. Clin Biochem 2005;38:1-8. (Pubitemid 39647648)
13. Bokenkamp A, Domanetzki M, Zinck R, Schumann G, Brodehl J. Reference values for cystatin C serum concentrations in children. Pediatr Nephrol 1998;12:125-129. (Pubitemid 28165801)
14. Vinge E, Lindergard B, Nilsson-Ehle P, Grubb A. Relationships among serum cystatin C, serum creatinine, lean tissue mass and glomerular filtration rate in healthy adults. Scand J Clin Lab Invest 1999;59:587-592. (Pubitemid 30082117)
15. Bjarnadottir M, Grubb A, Olafsson I. Promoter-mediated, dexamethasone-induced increase in cystatin C production by HeLa cells. Scand J Clin Lab Invest 1995;55:617-623.
16. Bokenkamp A, van Wijk JA, Lentze MJ, Stoffel-Wagner B. Effect of corticosteroid therapy on serum cystatin C and beta2-microglobulin concentrations. Clin Chem 2002;48:1123-1126. (Pubitemid 34680918)
17. Cimerman N, Brguljan PM, Krasovec M, Suskovic S, Kos J. Serum cystatin C, a potent inhibitor of cysteine proteinases, is elevated in asthmatic patients. Clin Chim Acta 2000;300:83-95. (Pubitemid 30665776)
18. Manzur AY, Kuntzer T, Pike M, Swan A. Glucocorticoid corticosteroids for Duchenne muscular dystrophy. Cochrane Database Syst Rev 2008:CD003725.
19. Mendell JR, Moxley RT, Griggs RC, Brooke MH, Fenichel GM, Miller JP, et al. Randomized, double-blind six-month trial of prednisone in Duchenne's muscular dystrophy. N Engl J Med 1989;320:1592-1597.
20. Moxley RT 3rd, Ashwal S, Pandya S, Connolly A, Florence J, Mathews K, et al. Practice parameter: corticosteroid treatment of Duchenne dystrophy: report of the Quality Standards Subcommittee of the American Academy of Neurology and the Practice Committee of the Child Neurology Society. Neurology 2005;64:13-20.
21. Finney H, Newman DJ, Gruber W, Merle P, Price CP. Initial evaluation of cystatin C measurement by particle-enhanced immunonephelometry on the Behring nephelometer systems (BNA, BN II). Clin Chem 1997;43:1016-1022. (Pubitemid 27246994)
22. Bokenkamp A, Domanetzki M, Zinck R, Schumann G, Byrd D, Brodehl J. Cystatin C-a new marker of glomerular filtration rate in children independent of age and height. Pediatrics 1998;101:875-881. (Pubitemid 28204840)
23. Newman DJ, Thakkar H, Edwards RG, Wilkie M, White T, Grubb AO, et al. Serum cystatin C measured by automated immunoassay: a more sensitive marker of changes in GFR than serum creatinine. Kidney Int 1995;47:312-318.
24. Minami R, Ishikawa Y. [Usefulness of serum cystatin C concentration as renal function marker in patients with Duchenne muscular dystrophy.] No To Hattatsu 2003;35:431-433.
25. Bahar A, Yilmaz Y, Unver S, Gocmen I, Karademir F. Reference values of umbilical cord and third-day cystatin C levels for determining glomerular filtration rates in newborns. J Int Med Res 2003;31:231-235. (Pubitemid 36805821)
26. Cataldi L, Mussap M, Bertelli L, Ruzzante N, Fanos V, Plebani M. Cystatin C in healthy women at term pregnancy and in their infant newborns: relationship between maternal and neonatal serum levels and reference values. Am J Perinatol 1999;16:287-295.
27. Galteau MM, Guyon M, Gueguen R, Siest G. Determination of serum cystatin C: biological variation and reference values. Clin Chem Lab Med 2001;39:850-857. (Pubitemid 32899137)
28. Helin I, Axenram M, Grubb A. Serum cystatin C as a determinant of glomerular filtration rate in children. Clin Nephrol 1998;49:221-225. (Pubitemid 28181562)
29. Kilpatrick ES, Keevil BG, Addison GM. Does adjustment of GFR to extracellular fluid volume improve the clinical utility of cystatin C? Arch Dis Child 2000;82:499-502.
30. Zaffanello M, Franchini M, Fanos V. Is serum Cystatin-C a suitable marker of renal function in children? Ann Clin Lab Sci 2007;37:233-240.
31. Holmquist P, Torffvit O, Sjoblad S. Metabolic status in diabetes mellitus affects markers for glomerular filtration rate. Pediatr Nephrol 2003;18:536-540. (Pubitemid 36790093)
32. Wiesli P, Schwegler B, Spinas GA, Schmid C. Serum cystatin C is sensitive to small changes in thyroid function. Clin Chim Acta 2003;338:87-90. (Pubitemid 37456694)
33. Foster J, Reisman W, Lepage N, Filler G. Influence of commonly used drugs on the accuracy of cystatin C-derived glomerular filtration rate. Pediatr Nephrol 2006;21:235-238. (Pubitemid 43115877)
34. Demirtas S, Akan O, Can M, Elmali E, Akan H. Cystatin C can be affected by non-renal factors: a preliminary study on leukemia. Clin Biochem 2006;39:115-118. (Pubitemid 43255498)
35. Satoshi T, Yuhei I, Kosuke U, Kazuo U. Serum cystatin-C values in children by age and their fluctuation during dehydration. Pediatr Int 2002;44:28-31. (Pubitemid 34146765)